Epidermal Growth Factor Receptor (EGFR) Signaling and Covalent EGFR Inhibition in Lung CancerHEUCKMANN, Johannes M; RAUH, Daniel; THOMAS, Roman K et al.Journal of clinical oncology. 2012, Vol 30, Num 27, pp 3417-3420, issn 0732-183X, 4 p.Article

Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion VariantsHEUCKMANN, Johannes M; BALKE-WANT, Hyatt; KÜPPERS, Ralf et al.Clinical cancer research (Print). 2012, Vol 18, Num 17, pp 4682-4690, issn 1078-0432, 9 p.Article

ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK InhibitorsHEUCKMANN, Johannes M; HÖLZEL, Michael; RAUH, Daniel et al.Clinical cancer research (Print). 2011, Vol 17, Num 23, pp 7394-7401, issn 1078-0432, 8 p.Article

The Novel Chimeric Anti-NCAM (Neural Cell Adhesion Molecule) Antibody ch.MK1 Displays Antitumor Activity in SCID Mice but Does not Activate Complement-Dependent Cytolysis (CDC)KLEHR, Martin; KOEHL, Ulrike; MÜHLENHOFF, Martina et al.Journal of immunotherapy (1997). 2009, Vol 32, Num 5, pp 442-451, issn 1524-9557, 10 p.Article

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerPEIFER, Martin; FERNANDEZ-CUESTA, Lynnette; MENON, Roopika et al.Nature genetics. 2012, Vol 44, Num 10, pp 1104-1110, issn 1061-4036, 7 p.Article

Insights into ALK-Driven Cancers Revealed through Development of Novel ALK Tyrosine Kinase InhibitorsLOVLY, Christine M; HEUCKMANN, Johannes M; DE STANCHINA, Elisa et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 14, pp 4920-4931, issn 0008-5472, 12 p.Article

Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance MutationSOS, Martin L; RODE, Haridas B; RUDDIGKEIT, Lars et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 3, pp 868-874, issn 0008-5472, 7 p.Article